JP2011195523A - Elastase activity inhibitor - Google Patents

Elastase activity inhibitor Download PDF

Info

Publication number
JP2011195523A
JP2011195523A JP2010065594A JP2010065594A JP2011195523A JP 2011195523 A JP2011195523 A JP 2011195523A JP 2010065594 A JP2010065594 A JP 2010065594A JP 2010065594 A JP2010065594 A JP 2010065594A JP 2011195523 A JP2011195523 A JP 2011195523A
Authority
JP
Japan
Prior art keywords
extract
elastase activity
skin
sesame
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010065594A
Other languages
Japanese (ja)
Other versions
JP5749445B2 (en
Inventor
Rie Ito
理恵 伊藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kose Corp
Original Assignee
Kose Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kose Corp filed Critical Kose Corp
Priority to JP2010065594A priority Critical patent/JP5749445B2/en
Publication of JP2011195523A publication Critical patent/JP2011195523A/en
Application granted granted Critical
Publication of JP5749445B2 publication Critical patent/JP5749445B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

PROBLEM TO BE SOLVED: To provide a novel elastase activity inhibitor having good safety.SOLUTION: The elastase activity inhibitor includes a Sesamum indicum sprout extract as an active ingredient.

Description

本発明は、新規なエラスターゼ活性阻害剤に関する。   The present invention relates to a novel elastase activity inhibitor.

エラスチン線維は、ヒト等のほ乳類や魚類などの体内の血管・靭帯・肺・皮膚をはじめとする、ほぼ全身の臓器・組織に分布する細胞外マトリックスの結合組織の線維の一種で、伸縮可能なαへリックス構造が架橋することによって形成され、組織の柔軟性維持に重要な役割を担っていることが知られている。一方、皮膚は表皮、真皮、皮下組織からなり、表皮は外部の乾燥や異物から体を守り、皮下組織は皮下脂肪等により外部からの衝撃を和らげ、真皮は線維芽細胞及びこれらの細胞の外にあって皮膚構造を支持する真皮細胞外マトリックスによって構成されており、皮膚の構造維持に重要な役割を果たしている。エラスチン線維は、皮膚では乳頭層の最下部で表皮面に平行に走る線維と乳頭層の中ほどの線維(elaunin fiber)、さらにそこから細い終末の線維が出て表皮の基底膜まで垂直に上がるもの(oxytalan fiber)があるとされている。   Elastin fiber is a type of connective tissue fiber in the extracellular matrix that is distributed in organs and tissues throughout the body, including blood vessels, ligaments, lungs, and skin in the body of mammals and fish such as humans. It is known that the α-helix structure is formed by cross-linking and plays an important role in maintaining the flexibility of the tissue. On the other hand, the skin consists of the epidermis, dermis, and subcutaneous tissue, the epidermis protects the body from external dryness and foreign matter, the subcutaneous tissue softens external impacts by subcutaneous fat, etc., and the dermis is fibroblasts and the outside of these cells. It is constituted by the dermal extracellular matrix that supports the skin structure and plays an important role in maintaining the structure of the skin. In the skin, elastin fibers run parallel to the epidermis surface at the bottom of the papillary layer, the middle fibers of the papillary layer (elaunin fiber), and then the thin terminal fibers come out and go vertically to the basement membrane of the epidermis It is said that there is a thing (oxytalan fiber).

皮膚のシワ形成、くすみ、きめの消失、弾力性の低下といった肌の老化といわれる現象は、加齢による線維芽細胞の増殖能の低下によるエラスチン線維等の産生能の低下が一因とされているが、皮膚の紫外線への暴露、空気の著しい乾燥、過度の皮膚洗浄等の外部刺激などが、エラスチン線維の分解を引き起こす結果、シワ形成、くすみ、きめの消失、弾力性の低下等を原因とする肌荒れや皮膚の老化などの症状が現れるともいわれている。   The phenomenon called skin aging such as skin wrinkle formation, dullness, loss of texture, and loss of elasticity is attributed to a decrease in the production ability of elastin fibers and the like due to a decrease in the proliferative ability of fibroblasts due to aging. However, external irritation such as exposure of the skin to ultraviolet rays, significant drying of the air, excessive skin washing, etc., causes degradation of the elastin fibers, resulting in wrinkle formation, dullness, loss of texture, loss of elasticity, etc. It is said that symptoms such as rough skin and aging of the skin appear.

エラスチン線維が分解する一因として、エラスターゼによる分解があると考えられている。エラスターゼはセリンプロテアーゼファミリーに属する酵素であり、例えば、膵エラスターゼは、膵の病変によって血中値が高くなることから各種膵疾患のマーカーとなっており、白血球由来のエラスターゼは、肉眼で確認できない初期の微小炎症においても血中濃度が上昇することが知られている。皮膚においては、例えば紫外線A波が照射された場合に微小炎症の蓄積があることが推察され、エラスターゼ活性が増加することが確認されている(例えば、特許文献1参照)。   It is considered that elastin fibers are degraded by elastase. Elastase is an enzyme belonging to the serine protease family. For example, pancreatic elastase is a marker for various pancreatic diseases because of increased blood levels due to pancreatic lesions. Elastase derived from leukocytes is an early stage that cannot be confirmed with the naked eye. It is known that the blood concentration also rises in the microinflammation. In skin, for example, it is speculated that there is accumulation of micro-inflammation when irradiated with ultraviolet A waves, and it has been confirmed that elastase activity increases (for example, see Patent Document 1).

このため、真皮におけるエラスターゼの作用を抑制し、エラスチン線維の分解を防止することが、シワやタルミ等の肌の老化防止に有効であるとされ、例えば、ブルセラ ランシフォリア抽出物(例えば、特許文献2参照)、スイートピー抽出物(例えば、特許文献3参照)、アイスランドモスの抽出物(例えば、特許文献4参照)、マンネンタケの抽出物(例えば、特許文献5参照)等、植物・真菌抽出物などを有効成分として含有するエラスターゼ活性阻害剤が提案されている。 For this reason, it is said that suppressing the action of elastase in the dermis and preventing the degradation of elastin fibers is effective for preventing skin aging such as wrinkles and tarmi. For example, Brucella rancifolia extract (for example, Patent Document 2) See), sweet pea extract (for example, see Patent Document 3), Iceland moss extract (for example, see Patent Document 4), mannentake extract (for example, see Patent Document 5), plant / fungal extract, etc. Has been proposed as an elastase activity inhibitor.

また、例えば、グルコサミン、グルコサミン誘導体又はそれらの塩(例えば、特許文献6参照)や、ホスホン酸誘導体、メルカプトプロピオンアミド誘導体等(例えば、特許文献7参照)や、コロソリン酸(例えば、特許文献8参照)や、1,6−ヘプタジエン−3,5−ジオン誘導体(例えば、特許文献9参照)などの化合物を有効成分として含有するエラスターゼ活性阻害剤が提案されている。   Further, for example, glucosamine, glucosamine derivatives or salts thereof (for example, see Patent Document 6), phosphonic acid derivatives, mercaptopropionamide derivatives (see, for example, Patent Document 7), corosolic acid (for example, see Patent Document 8). And elastase activity inhibitors containing compounds such as 1,6-heptadiene-3,5-dione derivatives (see, for example, Patent Document 9) as active ingredients.

一方、皮膚組織内のエラスターゼ活性が、毛周期と対応し、皮膚組織内エラスターゼ活性の上昇が毛包形成及びその成長に不可欠であることが報告されており(例えば、特許文献10参照)、エラスターゼ活性阻害剤を有効成分とする発毛抑制剤が提案されている(例えば、特許文献11参照)。   On the other hand, elastase activity in the skin tissue corresponds to the hair cycle, and it has been reported that an increase in the elastase activity in the skin tissue is essential for hair follicle formation and growth (see, for example, Patent Document 10). A hair growth inhibitor containing an activity inhibitor as an active ingredient has been proposed (see, for example, Patent Document 11).

ゴマは、ゴマ科(Pedaliaceae)ゴマ属(Sesamum)の単年草植物で、栽培種はSesamuun indicum L.である。ゴマ種子の発芽体(もやし)から得られる成分の香粧品分野における利用については、マクロファージを活性化させることによる免疫賦活効果(例えば、特許文献12参照)、ヒドロキシラジカル消去活性効果(例えば、特許文献13参照)等が開示され、ゴマ種子発芽体抽出物の様々な効果が注目されている。
しかしながら、ゴマ発芽体抽出物の有効性において、エラスターゼ活性阻害剤として応用することに関しては全く知られていない。
Sesame is an annual plant of Pedaliaceae Sesamum, and the cultivated species is Sesamuun indicum L. Regarding the use in the cosmetics field of components obtained from germinated sesame seeds (sprouts), immunostimulatory effect by activating macrophages (for example, see Patent Document 12), hydroxy radical scavenging activity effect (for example, Patent Document) 13) and the like, and various effects of the sesame seed germination extract are attracting attention.
However, it is not known at all about application as an elastase activity inhibitor in the effectiveness of the extract of sesame seeds.

特許第3749769号公報Japanese Patent No. 3749769 特開2002−255734号公報JP 2002-255734 A 特開2006−282617号公報JP 2006-282617 A 特開2007−302607号公報JP 2007-302607 A 特開2005−23021号公報JP-A-2005-23021 特開2004−83432号公報JP 2004-83432 A 特開2006−104209号公報JP 2006-104209 A 特開2006−265232号公報JP 2006-265232 A 特開2006−347897号公報JP 2006-347897 A 特開平11−199450号公報JP-A-11-199450 特開2005−343887号公報JP 2005-343887 A 特開2006−298773号公報JP 2006-298773 A 特開平08−231953号公報Japanese Patent Laid-Open No. 08-231953

上記した従来のエラスターゼ活性阻害剤は、安全性、安定性等が確認されていないものもあり、エラスターゼ活性阻害活性効果が十分確認されていない場合もある。したがって、本発明の課題は、エラスターゼ活性を抑制する効果の高い化合物を有効成分とするエラスターゼ活性阻害剤を提供することにある。   Some of the conventional elastase activity inhibitors described above have not been confirmed to be safe, stable, etc., and the elastase activity inhibitory activity effect may not be fully confirmed. Therefore, the subject of this invention is providing the elastase activity inhibitor which uses the compound with the high effect of suppressing elastase activity as an active ingredient.

本発明者は上記課題を解決するため、種々の植物抽出物について鋭意検討した結果、ゴマ発芽体からの抽出物が、エラスターゼ活性阻害効果を示すものであることを見出し、本発明を完成した。   As a result of intensive studies on various plant extracts in order to solve the above-mentioned problems, the present inventors have found that an extract from sesame seeds shows an elastase activity inhibitory effect and completed the present invention.

本発明によれば、安全性が良好な、新規なエラスターゼ活性阻害剤を提供することができる。   According to the present invention, a novel elastase activity inhibitor with good safety can be provided.

エラスターゼ活性阻害効果評価試験及びその結果を示す図。The figure which shows the elastase activity inhibitory effect evaluation test and its result.

以下、本発明について詳細に説明する。なお、本明細書において、「〜」はその前後の数値を含む範囲を意味するものとする。   Hereinafter, the present invention will be described in detail. In the present specification, “to” means a range including numerical values before and after.

本発明に用いるゴマ発芽体(Sesamum
indicum Lenne)は、ゴマ科ゴマ属の植物で、培煎等の高温処理を施していないものであれば、白ゴマ、黒ゴマ等の種類、産地を問わず使用できる。これを、水中または水分を含有できる適当な培地、例えば寒天、石英砂、海砂、脱脂綿、砂、土等の好ましくは滅菌処理した培地に均一に撒き、10〜50℃、好ましくは30〜40℃にて水分を適時に補いながら、5〜100時間、好ましくは24〜72時間培養を行う。これより短いと発芽が十分ではなく、長いと葉が出てしまうため好ましくない。培養は照光下または暗条件下のいずれでも構わない。
Sesame germination (Sesamum) used in the present invention
indicum Lenne) is a plant belonging to the sesame family Sesame genus and can be used regardless of the type and production area of white sesame, black sesame, etc., as long as it has not been subjected to high temperature treatment such as brewing broth. This is evenly spread on a suitable medium capable of containing water or water, such as agar, quartz sand, sea sand, absorbent cotton, sand, earth, etc., preferably a sterilized medium, and 10-50 ° C., preferably 30-40 Culturing is performed for 5 to 100 hours, preferably 24 to 72 hours while supplementing water at a suitable time. If the length is shorter than this, germination is not sufficient, and if it is longer, leaves are not preferable. Culture may be performed under illumination or in dark conditions.

本ゴマ発芽体抽出物は、一般的な方法で調製することができる。抽出溶媒としては特に限定されないが、例えば、水;メチルアルコール、エチルアルコール等の低級一価アルコール;グリセリン、プロピレングリコール、1,3−ブチレングリコール等の液状多価アルコール;アセトン等のケトン類;エチルエーテル等のエーテル類;酢酸エチル等のエステル類;等の一種又は二種以上を用いることができる。抽出は、前記ゴマ発芽体抽出物を室温又は加温下で溶媒中に所定の時間浸漬することによって実施できる。また、抽出前に、乾燥、細切、圧搾又は醗酵等の前処理を行うこともできる。   This sesame germinant extract can be prepared by a general method. Although it does not specifically limit as an extraction solvent, For example, Water; Lower monohydric alcohols, such as methyl alcohol and ethyl alcohol; Liquid polyhydric alcohols, such as glycerol, propylene glycol, and 1, 3- butylene glycol; Ketones, such as acetone; Ethyl One or more of ethers such as ether; esters such as ethyl acetate; and the like can be used. Extraction can be performed by immersing the sesame germinant extract in a solvent at room temperature or under heating for a predetermined time. Moreover, pre-processing, such as drying, shredding, pressing or fermentation, can also be performed before extraction.

前記ゴマ発芽体抽出物は、調製後、そのままエラスターゼ活性阻害剤として用いることができる。また、所望により、適宜の期間そのまま放置し熟成させた後に、エラスターゼ活性阻害剤として用いることもできる。必要ならば、本発明の効果に影響のない範囲で、更に、濾過又はイオン交換樹脂等により、脱臭、脱色等の精製処理を施して用いることもできる。又、液体クロマトグラフィー等の分離手段を用い、活性の高い画分を取り出して用いることもできる。   The sesame germinant extract can be used directly as an elastase activity inhibitor after preparation. Further, if desired, it can be used as an elastase activity inhibitor after being left to mature for an appropriate period. If necessary, it can be used after being subjected to a purification treatment such as deodorization and decolorization by filtration or ion exchange resin within a range that does not affect the effect of the present invention. Further, a fraction having high activity can be taken out and used by using a separation means such as liquid chromatography.

前記ゴマ発芽体抽出物は、液状、ペースト状、ゲル状等いずれの形態であってもよい。すなわち、抽出溶媒を含む液状の抽出液をそのままあるいは濃縮してから用いても良いし、また、抽出液を減圧乾燥、又は凍結乾燥などにより乾固させて固体状とした後に用いることもできる。また、スプレードライ等により乾燥させて粉末として用いることもできる。また更には、これら固体状あるいは粉末の抽出物を適宜溶媒に再溶解して抽出液として用いても良い。   The sesame germinant extract may be in any form such as liquid, paste or gel. That is, the liquid extract containing the extraction solvent may be used as it is or after being concentrated, or may be used after the extract is dried and solidified by drying under reduced pressure or freeze drying. It can also be dried by spray drying or the like and used as a powder. Furthermore, these solid or powder extracts may be appropriately redissolved in a solvent and used as an extract.

本発明のエラスターゼ活性阻害剤は、種々の用途に用いることができる。本発明のエラスターゼ活性阻害剤は、安全性も高く、また配合時の安定性にも優れているので、食品(飲料も含む)への配合や、化粧料又は皮膚外用剤の有効成分として用いるのが好ましい。   The elastase activity inhibitor of the present invention can be used for various applications. Since the elastase activity inhibitor of the present invention has high safety and excellent stability at the time of blending, it can be used as an active ingredient for blending into foods (including beverages) and cosmetics or skin external preparations. Is preferred.

本発明のエラスターゼ活性阻害剤を含有する化粧料又は皮膚外用剤は、皮膚に適用することにより、エラスターゼの活性を抑制する。その結果、エラスチンの過剰な分解が起こらず、皮膚の柔軟性や弾力性が維持され、たるみ・しわなどの老徴現象が改善される。即ち、老化防止用化粧料又は皮膚外用剤、及びしわ・たるみ改善用化粧料又は皮膚外用剤として優れた効果を奏する。
また、エラスターゼは、炎症反応における免疫細胞の遊走に関与している可能性があるので、本発明のエラスターゼ活性阻害剤を含有する炎症抑制用化粧料又は皮膚外用剤としても有用である。
さらに、エラスターゼは、毛包形成に関与している可能性があるので、本発明のエラスターゼ活性阻害剤を含有する化粧料又は皮膚外用剤は、発毛及び育毛を制御する化粧料又は皮膚外用剤としても有用である。
A cosmetic or external preparation for skin containing the elastase activity inhibitor of the present invention suppresses the activity of elastase when applied to the skin. As a result, excessive degradation of elastin does not occur, skin flexibility and elasticity are maintained, and senile phenomena such as sagging and wrinkles are improved. That is, it has excellent effects as an anti-aging cosmetic or a skin external preparation, and a wrinkle / sag improvement cosmetic or a skin external preparation.
In addition, since elastase may be involved in immune cell migration in an inflammatory reaction, it is also useful as an anti-inflammatory cosmetic or external skin preparation containing the elastase activity inhibitor of the present invention.
Furthermore, since elastase may be involved in hair follicle formation, the cosmetic or skin external preparation containing the elastase activity inhibitor of the present invention is a cosmetic or skin external preparation that controls hair growth and hair growth. It is also useful.

前記化粧料又は皮膚外用剤中における、本発明のエラスターゼ活性阻害剤の配合量は特に限定されてないが、一般的には、エラスターゼ活性阻害の観点から全組成に対して固形分に換算して好ましくは0.0001〜1質量%(以下単に%で表す)であるのが好ましく、より好ましくは0.001〜0.1%である。この範囲内であれば、本発明のエラスターゼ活性阻害剤を安定に配合することができ、かつ高い老化防止効果やたるみ・しわ改善効果を発揮することができる。   The blending amount of the elastase activity inhibitor of the present invention in the cosmetic or the external preparation for skin is not particularly limited, but generally, it is converted into solid content with respect to the total composition from the viewpoint of inhibiting elastase activity. The content is preferably 0.0001 to 1% by mass (hereinafter simply expressed as%), more preferably 0.001 to 0.1%. Within this range, the elastase activity inhibitor of the present invention can be stably blended, and a high anti-aging effect and sagging / wrinkle improving effect can be exhibited.

また、前記化粧料又は皮膚外用剤中には、本発明の効果を損なわない範囲で他の有効成分、例えば、美白効果、老化防止効果、又は紫外線暴露によるシワ形成抑制効果等を奏する他の有効成分、を配合してもよい。より具体的には、紫外線防御剤、抗菌剤、美白剤、抗炎症剤、細胞賦活剤、活性酸素除去剤、保湿剤等を挙げることができるが、これらに限定されることはない。 In the cosmetic or external preparation for skin, other active ingredients such as a whitening effect, an anti-aging effect, or an effect of suppressing wrinkle formation due to exposure to ultraviolet rays are within the range not impairing the effects of the present invention. Ingredients may be blended. More specifically, examples include, but are not limited to, UV protection agents, antibacterial agents, whitening agents, anti-inflammatory agents, cell activators, active oxygen scavengers, moisturizers and the like.

紫外線防御剤は、例えばベンゾフェノン系化合物、PABA系化合物、ケイ皮酸系化合物、サリチル酸系化合物があげられ、より具体的には、4−tert−ブチル−4’−メトキシジベンゾイルメタン、p−メトキシ桂皮酸−2−エチルへキシル、2−ヒドロキシ−4−メトキシベンゾフェノン、2−フェニル−ベンズイミダゾール−5−硫酸ナトリウム、酸化チタン、酸化亜鉛等を挙げることができる。   Examples of the UV protection agent include benzophenone compounds, PABA compounds, cinnamic acid compounds, and salicylic acid compounds, and more specifically, 4-tert-butyl-4′-methoxydibenzoylmethane, p-methoxy. Examples include 2-ethylhexyl cinnamate, 2-hydroxy-4-methoxybenzophenone, 2-phenyl-benzimidazole-5-sodium sulfate, titanium oxide, and zinc oxide.

抗菌剤は、例えば、安息香酸、安息香酸ナトリウム、パラオキシ安息香酸エステル、塩化ベンザルコニウム、フェノキシエタノール、イソプロピルメチルフェノール等が挙げられる。   Examples of the antibacterial agent include benzoic acid, sodium benzoate, p-hydroxybenzoate ester, benzalkonium chloride, phenoxyethanol, isopropylmethylphenol, and the like.

美白剤は、日焼け等により生じる皮膚の黒化、色素沈着により生ずるシミ、ソバカス等の発生を防止する作用を有しており、例えばアルブチン、エラグ酸、リノール酸、ビタミンC及び誘導体、ビタミンE及びその誘導体、グリチルリチン酸及びその誘導体、グリチルレチン酸及びその誘導体、トラネキサム酸、胎盤抽出物、カミツレ抽出物、カンゾウ抽出物、エイジツ抽出物、オウゴン抽出物、海藻抽出物、クジン抽出物、ケイケットウ抽出物、ゴカヒ抽出物、コメヌカ抽出物、小麦胚芽抽出物、サイシン抽出物、サンザイシ抽出物、サンペンズ抽出物、シラユリ抽出物、シャクヤク抽出物、センプクカ抽出物、大豆抽出物、茶抽出物、糖蜜抽出物、ビャクレン抽出物、ブドウ抽出物、ホップ抽出物、マイカイカ抽出物、モッカ抽出物、ユキノシタ抽出物等が挙げられる。   The whitening agent has the effect of preventing the occurrence of darkening of the skin caused by sunburn or the like, stains caused by pigmentation, buckwheat, etc., such as arbutin, ellagic acid, linoleic acid, vitamin C and derivatives, vitamin E and Its derivatives, glycyrrhizic acid and its derivatives, glycyrrhetinic acid and its derivatives, tranexamic acid, placenta extract, chamomile extract, licorice extract, age extract, sea urchin extract, seaweed extract, cucumber extract, coconut extract, Gokahi extract, rice bran extract, wheat germ extract, saicin extract, hawthorn extract, sunpens extract, shirayuri extract, peonies extract, sempukuka extract, soybean extract, tea extract, molasses extract, beechlen Extract, Grape extract, Hop extract, Mikaika extract, Mokka extract, Yu Noshita extract, and the like.

抗炎症剤は、日焼け後の皮膚のほてりや紅斑等の炎症を抑制する作用を有しており、例えば、イオウ及びその誘導体、グリチルリチン酸及びその誘導体、グリチルレチン酸及びその誘導体、アルテア抽出物、アシタバ抽出物、アルニカ抽出物、インチンコウ抽出物、イラクサ抽出物、オウバク抽出物、オトギソウ抽出物、カミツレ抽出物、キンギンカ抽出物、クレソン抽出物、コンフリー抽出物、サルビア抽出物、シコン抽出物、シソ抽出物、シラカバ抽出物、ゲンチアナ抽出物等が挙げられる。   Anti-inflammatory agents have the effect of suppressing inflammation such as hot flashes and erythema on the skin after sunburn. For example, sulfur and its derivatives, glycyrrhizic acid and its derivatives, glycyrrhetinic acid and its derivatives, Altea extract, Ashitaba Extract, Arnica extract, Ginseng extract, Nettle extract, Oat extract, Hypericum extract, Chamomile extract, Snapdragon extract, Watercress extract, Comfrey extract, Salvia extract, Shikon extract, Perilla extract Product, birch extract, gentian extract and the like.

細胞賦活剤は、肌荒れの改善等の目的で用いられ、例えば、カフェイン、鶏冠抽出物、貝殻抽出物、ローヤルゼリー、シルクプロテイン及びその分解物又はそれらの誘導体、ラクトフェリン又はその分解物、コンドロイチン硫酸、ヒアルロン酸等のムコ多糖類またはそれらの塩、コラーゲン、酵母抽出物、乳酸菌抽出物、ビフィズス菌抽出物、醗酵代謝抽出物、イチョウ抽出物、オオムギ抽出物、センブリ抽出物、タイソウ抽出物、ニンジン抽出物、ローズマリー抽出物、グリコール酸、クエン酸、乳酸、リンゴ酸、酒石酸、コハク酸等が挙げられる。   The cell activator is used for the purpose of improving rough skin, such as caffeine, chicken crown extract, shell extract, royal jelly, silk protein and its degradation product or derivatives thereof, lactoferrin or its degradation product, chondroitin sulfate, Mucopolysaccharides such as hyaluronic acid or their salts, collagen, yeast extract, lactic acid bacterium extract, bifidobacteria extract, fermentation metabolic extract, ginkgo biloba extract, barley extract, sembly extract, beetle extract, carrot extract Products, rosemary extract, glycolic acid, citric acid, lactic acid, malic acid, tartaric acid, succinic acid and the like.

活性酸素除去剤は、過酸化脂質生成抑制剤等の作用を有しており、例えば、スーパーオキシドディスムターゼ、マンニトール、クエルセチン、カテキン及びその誘導体、ルチン及びその誘導体、ボタンピ抽出物、ヤシャジツ抽出物、メリッサ抽出物、羅漢果抽出物、レチノール及びその誘導体、カロチノイド等のビタミンA類、チアミン及びその誘導体、リボフラビンおよびその誘導体、ピリドキシンおよびその誘導体、ニコチン酸及びその誘導体等のビタミンB類、トコフェロール及びその誘導体等のビタミンE類、ジブチルヒドロキシトルエン及びブチルヒドロキシアニソール等が挙げられる。   The active oxygen scavenger has an action such as a lipid peroxide production inhibitor, such as superoxide dismutase, mannitol, quercetin, catechin and derivatives thereof, rutin and derivatives thereof, button pi extract, yashajitsu extract, melissa Extracts, Rahan fruit extract, retinol and its derivatives, vitamin A such as carotenoid, thiamine and its derivatives, riboflavin and its derivatives, pyridoxine and its derivatives, vitamin B such as nicotinic acid and its derivatives, tocopherol and its derivatives, etc. Vitamin E, dibutylhydroxytoluene and butylhydroxyanisole.

保湿剤は、例えば、エラスチン、ケラチン等のタンパク質またはそれらの誘導体、加水分解並びにそれらの塩、グリシン、セリン、アスオアラギン酸、グルタミン酸、アルギニン、テアニン等のアミノ酸及びそれらの誘導体、ソルビトール、エリスリトール、トレハロース、イノシトール、グルコース、蔗糖およびその誘導体、デキストリン及びその誘導体、ハチミツ等の糖類、D−パンテノール及びその誘導体、尿素、リン脂質、セラミド、オウレン抽出物、ショウブ抽出物、ジオウ抽出物、センキュウ抽出物、ゼニアオイ抽出物、タチジャコウ抽出物、ドクダミ抽出物、ハマメリス抽出物、ボダイジュ抽出物、マロニエ抽出物、マルメロ抽出物等が挙げられる。   The humectant includes, for example, proteins such as elastin and keratin or derivatives thereof, hydrolysis and salts thereof, amino acids such as glycine, serine, asoaraginic acid, glutamic acid, arginine and theanine and derivatives thereof, sorbitol, erythritol, trehalose, Inositol, glucose, sucrose and derivatives thereof, dextrin and derivatives thereof, saccharides such as honey, D-panthenol and derivatives thereof, urea, phospholipid, ceramide, auren extract, camphor extract, diau extract, senkyu extract, Examples of this include mallow mushroom extract, ginger extract, dokudami extract, hamamelis extract, bodaige extract, maronier extract, quince extract and the like.

また、前記化粧料又は皮膚外用剤には、本発明の効果を損なわない範囲で、化粧料や医薬部外品、皮膚外用剤等の製造に通常使用される成分、例えば、水(精製水、温泉水、深層水等)、油剤、界面活性剤、金属セッケン、ゲル化剤、粉体、アルコール類、水溶性高分子、皮膜形成剤、樹脂、包接化合物、抗菌剤、香料、消臭剤、塩類、pH調整剤、清涼剤、植物・動物・微生物由来の抽出物、活性酸素除去剤、血行促進剤、収斂剤、抗脂漏剤、保湿剤、キレート剤、角質溶解剤、酵素、ホルモン類、外のビタミン類等を必要に応じて添加することができる。   In addition, the cosmetic or skin external preparation may be used in the manufacture of cosmetics, quasi drugs, skin external preparations, and the like, such as water (purified water, Hot spring water, deep water, etc.), oil agent, surfactant, metal soap, gelling agent, powder, alcohol, water-soluble polymer, film-forming agent, resin, inclusion compound, antibacterial agent, fragrance, deodorant , Salts, pH adjusters, fresheners, extracts derived from plants, animals and microorganisms, active oxygen scavengers, blood circulation promoters, astringents, antiseborrheic agents, moisturizers, chelating agents, keratolytic agents, enzymes, hormones Other vitamins can be added as needed.

以下、本発明を実施例によりさらに具体的に説明するが、本発明の範囲は下記の実施例に限定されることはない。
[製造例1:ゴマ発芽体抽出物の調製1]
予め滅菌した石英砂をステンレス製のバットに敷き、その上に中国産ゴマ種子を撒き、蒸留水を十分に噴霧しながら、40℃の恒温槽中で培養し発芽させた。発芽率は80%以上であった。状態が同程度の発芽体全草部100gを、1Lの70%エチルアルコール水溶液に入れ、加熱還流して抽出した。不溶物を濾過後、ろ液を減圧下で濃縮して固形のゴマ発芽体抽出物を得た。
[実施例1:エラスターゼ活性阻害試験]
試験溶液として、上記ゴマ発芽体抽出物の固形分濃度として、0.1%溶液を調製した。ここでの試料は、体積比率でエタノール:水=1:1の混合溶液を使用した。
エラスターゼ活性阻害試験は、豚由来のエラスターゼ酵素液(シグマ社製)、及びN-Succinyl-Ala-Ala-Ala-p-nitroanilideを基質として、具体的には、以下の通り行った。
酵素液は、0.05units/mL濃度に調整した。
基質液は、基質をジメチルスルフォキサイド(DMSO)に溶解し、0.1mol/L濃度の溶液とした後、0.05mol/L Tris-HCl(pH8.8)緩衝液で希釈し、1mmol/L濃度の溶液として調製した。
基質液100μLと、1%試料溶液50μLとを混合した後、酵素液50μLを添加し、37℃、30分間反応させた。その後分光光度計により波長405nmの吸光度を測定し、生成したnitroaniline量を求め、エラスターゼ活性阻害率を算出した。エラスターゼ活性阻害率は以下の式により算出した。

エラスターゼ活性阻害率(%)={1−(A−B)/(C−D)}×100

A:基質液と試料溶液とを混合した後、酵素液を添加した時の混合液の波長405nmの吸光度
B:基質液と試料溶液とを混合した時の混合液の波長405nmの吸光度
C:試料溶液の代わりに、該溶液の溶媒を基質液と上記割合で混合した後、酵素液を添加した時の混合液の波長405nmの吸光度
D:試料溶液も酵素液も添加していない、基質液の405nmの吸光度
Hereinafter, the present invention will be described more specifically with reference to examples. However, the scope of the present invention is not limited to the following examples.
[Production Example 1: Preparation 1 of Sesame Germ Extract]
Pre-sterilized quartz sand was spread on a stainless steel vat, Chinese sesame seeds were sown on it, and cultured and germinated in a constant temperature bath at 40 ° C. while thoroughly sprayed with distilled water. The germination rate was 80% or more. 100 g of germinated whole plant parts having the same state were put into 1 L of 70% aqueous ethyl alcohol solution and extracted by heating under reflux. The insoluble material was filtered, and the filtrate was concentrated under reduced pressure to obtain a solid sesame germinant extract.
[Example 1: Elastase activity inhibition test]
As a test solution, a 0.1% solution was prepared as a solid content concentration of the sesame germinated extract. The sample used here was a mixed solution of ethanol: water = 1: 1 by volume ratio.
The elastase activity inhibition test was performed as follows using elastase enzyme solution derived from swine (manufactured by Sigma) and N-Succinyl-Ala-Ala-Ala-p-nitronelide as substrates.
The enzyme solution was adjusted to a concentration of 0.05 units / mL.
The substrate solution was prepared by dissolving the substrate in dimethyl sulfoxide (DMSO) to obtain a 0.1 mol / L concentration solution, and then diluting with 0.05 mol / L Tris-HCl (pH 8.8) buffer solution to obtain 1 mmol. / L concentration solution was prepared.
After mixing 100 μL of the substrate solution and 50 μL of the 1% sample solution, 50 μL of the enzyme solution was added and reacted at 37 ° C. for 30 minutes. Thereafter, the absorbance at a wavelength of 405 nm was measured with a spectrophotometer, the amount of produced nitroaniline was determined, and the elastase activity inhibition rate was calculated. The elastase activity inhibition rate was calculated by the following formula.

Elastase activity inhibition rate (%) = {1− (A−B) / (C−D)} × 100

A: Absorbance at a wavelength of 405 nm of the mixed solution when the enzyme solution is added after mixing the substrate solution and the sample solution B: Absorbance at a wavelength of 405 nm of the mixed solution when the substrate solution and the sample solution are mixed C: Sample Instead of the solution, after the solvent of the solution is mixed with the substrate solution in the above ratio, the absorbance at a wavelength of 405 nm of the mixture solution when the enzyme solution is added. D: The sample solution and the enzyme solution are not added. Absorbance at 405 nm

また、本発明のゴマ発芽体抽出物のエラスターゼ活性阻害効果を検証するために、比較対象としてRoche社製造のコンプリートプロテアーゼインヒビターカクテル、及びエラスターゼ活性阻害剤として公知(例えば特開2003−2820)であるマリーゴールド抽出物(CALENDULAOFFICINALIS. キク科)を用いた。本発明で使用したコンプリートプロテアーゼインヒビターカクテルは多種のプロテアーゼについて常に一定の阻害能をもつ試薬で本エラスターゼについても効果があることが既に確認されている。結果を、ゴマ発芽体抽出物の結果とともに、図1に併せて示す。
図1のグラフに示した結果から、本発明のエラスターゼ活性阻害剤は、コンプリートプロテアーゼインヒビターカクテルと同等の顕著なエラスターゼ活性阻害作用を有していることがわかった。またマリーゴールド抽出物と比較して十分に高いエラスターゼ活性阻害作用を有していることがわかった。従って、本発明のエラスターゼ活性阻害剤を用いることによって、より高いエラスターゼ活性阻害作用を得ることができる。又、従来より配合量を減少した場合においても同等以上の効果が得られるので、配合組成の選択の幅が広がり、本発明のエラスターゼ活性阻害剤を用いることは、製剤上有利である。
In addition, in order to verify the elastase activity inhibitory effect of the sesame seed germ extract of the present invention, it is known as a complete protease inhibitor cocktail manufactured by Roche and an elastase activity inhibitor (for example, JP-A-2003-2820). Marigold extract (CALENDULAOFFICINALIS. Asteraceae) was used. It has already been confirmed that the complete protease inhibitor cocktail used in the present invention is a reagent that always has a certain inhibitory ability for various proteases and is effective for the present elastase. A result is combined with the result of a sesame germination extract, and is shown collectively in FIG.
From the results shown in the graph of FIG. 1, it was found that the elastase activity inhibitor of the present invention has a remarkable elastase activity inhibitory effect equivalent to that of the complete protease inhibitor cocktail. Moreover, it turned out that it has a sufficiently high elastase activity inhibitory effect compared with a marigold extract. Therefore, by using the elastase activity inhibitor of the present invention, a higher elastase activity inhibitory action can be obtained. In addition, even when the blending amount is reduced from the conventional level, the same or higher effect can be obtained. Therefore, the range of selection of the blending composition is widened, and it is advantageous in terms of formulation to use the elastase activity inhibitor of the present invention.

以下は、本発明のエラスターゼ活性阻害剤を含有する抽出物、化粧料又は皮膚外用剤の例である。
[製造例2:ゴマ発芽体抽出物の調製2]
37℃で2日間培養し発芽させたゴマ種子(インド産)を培地から分離した後、ホモジナイザーで粉砕したもの100gを、50%ジプロピレングリコール溶液1Lにて適宜攪拌しながら40℃で20時間抽出した。24時間放置して沈殿物をろ過し抽出物を得た。本抽出物の固形分濃度は2.0%であった。
[製造例3:ゴマ発芽体抽出物の調製3]
実施例1と同様の方法で40℃で2日間培養し発芽させたゴマ種子(中国産)の発芽体200gを、精製水1Lに適宜攪拌しながら冷暗所で72時間抽出、ろ過した。このろ液が半量になるまで減圧下で濃縮し1,3ブチレングリコール及び精製水を加え1,3ブチレングリコール濃度が30%になるように調整した。本抽出物の固形分濃度は5.0%であった。
[実施例2:洗顔料]
(製法)
A.下記成分(1)〜(7)を加熱溶解する。
B.下記成分(8)〜(11)を加熱溶解する。
C.AにBを加え混合する。
D.Cを冷却後、下記成分(12)〜(14)を加え混合し、洗顔料を得た。
The following are examples of extracts, cosmetics or external preparations for skin containing the elastase activity inhibitor of the present invention.
[Production Example 2: Preparation 2 of Sesame Germ Extract]
Sesame seeds (indian) cultivated for 2 days at 37 ° C and germinated were separated from the medium, and then pulverized with a homogenizer, 100 g was extracted at 40 ° C for 20 hours with 1 L of 50% dipropylene glycol solution. did. The precipitate was filtered by leaving it for 24 hours to obtain an extract. The solid content concentration of this extract was 2.0%.
[Production Example 3: Preparation 3 of Sesame Germ Extract]
200 g of germinated sesame seeds (produced in China) that were cultured and germinated at 40 ° C. for 2 days in the same manner as in Example 1 were extracted and filtered in 1 L of purified water for 72 hours in a cool and dark place. The filtrate was concentrated under reduced pressure until the volume was reduced to half, and 1,3-butylene glycol and purified water were added to adjust the concentration of 1,3-butylene glycol to 30%. The solid content concentration of this extract was 5.0%.
[Example 2: Face wash]
(Manufacturing method)
A. The following components (1) to (7) are dissolved by heating.
B. The following components (8) to (11) are dissolved by heating.
C. Add B to A and mix.
D. After cooling C, the following components (12) to (14) were added and mixed to obtain a face wash.

(成分) (%)
(1)ラウリン酸 5.0
(2)ミリスチン酸 18.5
(3)ステアリン酸 6.0
(4)グリセリン 12.0
(5)ポリエチレングリコール1500 5.0
(6)水酸化カリウム 6.5
(7)精製水 残量
(8)ヤシ油脂肪酸ジエタノールアミド 5.0
(9)ヤシ油脂肪酸メチルタウリンナトリウム 1.8
(10)ポリオキシエチレン(7.5E.O.)ラウリルエーテル 2.0
(11)ジステアリン酸エチレングリコール 1.0
(12)ヒドロキシプロピルメチルセルロース1%水溶液 5.0
(13)製造例1のゴマ発芽体抽出物 0.01
(14)香料 適量
(Ingredient) (%)
(1) Lauric acid 5.0
(2) Myristic acid 18.5
(3) Stearic acid 6.0
(4) Glycerin 12.0
(5) Polyethylene glycol 1500 5.0
(6) Potassium hydroxide 6.5
(7) Purified water remaining amount (8) Palm oil fatty acid diethanolamide 5.0
(9) Palm oil fatty acid methyl taurine sodium 1.8
(10) Polyoxyethylene (7.5E.O.) lauryl ether 2.0
(11) Ethylene glycol distearate 1.0
(12) Hydroxypropyl methylcellulose 1% aqueous solution 5.0
(13) Sesame germinant extract of Production Example 1 0.01
(14) Perfume appropriate amount

[実施例3:化粧水]
(製法)
A.下記成分(1)〜(6)を混合溶解する。
B.下記成分(7)〜(12)を混合溶解する。
C.AにBを加え混合し、化粧水を得た。
[Example 3: lotion]
(Manufacturing method)
A. The following components (1) to (6) are mixed and dissolved.
B. The following components (7) to (12) are mixed and dissolved.
C. B was added to A and mixed to obtain a skin lotion.

(成分) (%)
(1)クエン酸 0.05
(2)クエン酸ナトリウム 0.2
(3)ピロリドンカルボン酸ナトリウム(50%)液 0.5
(4)グリチルリチン酸ジカリウム 0.1
(5)グリセリン 3.0
(6)1,3−ブチレングリコール 8.0
(7)精製水 残量
(8)エタノール 10.0
(9)製造例2のゴマ発芽体抽出物 2.0
(10)香料 適量
(11)防腐剤 適量
(12)モノオレイン酸ポリオキシエチレン(20E.O.)
ソルビタン 0.5
(Ingredient) (%)
(1) Citric acid 0.05
(2) Sodium citrate 0.2
(3) Sodium pyrrolidonecarboxylate (50%) solution 0.5
(4) Dipotassium glycyrrhizinate 0.1
(5) Glycerin 3.0
(6) 1,3-butylene glycol 8.0
(7) Purified water remaining amount (8) Ethanol 10.0
(9) Sesame germinant extract of Production Example 2 2.0
(10) Perfume Appropriate amount (11) Preservative Appropriate amount (12) Polyoxyethylene monooleate (20E.O.)
Sorbitan 0.5

[実施例4:乳液(水中油型)]
(製法)
A.下記成分(1)〜(13)を加熱溶解し、70℃に保つ。
B.下記成分(14)〜(19)を加熱溶解し、70℃に保つ。
C.AにBを加え乳化し、更に下記成分(20)を加え混合する。
D.Cを冷却し、下記成分(21)を加え混合し、乳液を得た。
[Example 4: Latex (oil-in-water type)]
(Manufacturing method)
A. The following components (1) to (13) are dissolved by heating and maintained at 70 ° C.
B. The following components (14) to (19) are dissolved by heating and maintained at 70 ° C.
C. B is added to A to emulsify, and the following component (20) is further added and mixed.
D. C was cooled, the following component (21) was added and mixed to obtain an emulsion.

(成分) (%)
(1)ステアリン酸 1.0
(2)セタノール 0.5
(3)モノステアリン酸グリセリン 0.5
(4)流動パラフィン 2.0
(5)スクワラン 3.0
(6)ホホバ油 3.0
(7)パルミチン酸セチル 0.2
(8)パルミチン酸レチノール 0.2
(9)酢酸トコフェロール 0.05
(10)防腐剤 適量
(11)モノステアリン酸ソルビタン 0.3
(12)モノオレイン酸ポリオキシエチレン(20E.O.)
ソルビタン 0.5
(13)ジブチルヒドロキシトルエン 0.1
(14)トリエタノールアミン 0.5
(15)1,3−ブチレングリコール 15.0
(16)グリセリン 3.0
(17)ポリエチレングリコール6000 0.5
(18)製造例3のゴマ発芽体抽出物 2.0
(19)精製水 残量
(20)カルボキシビニルポリマー1%水溶液 8.0
(21)香料 適量
(Ingredient) (%)
(1) Stearic acid 1.0
(2) Cetanol 0.5
(3) Glycerol monostearate 0.5
(4) Liquid paraffin 2.0
(5) Squalane 3.0
(6) Jojoba oil 3.0
(7) Cetyl palmitate 0.2
(8) Retinol palmitate 0.2
(9) Tocopherol acetate 0.05
(10) Preservative appropriate amount (11) Sorbitan monostearate 0.3
(12) Polyoxyethylene monooleate (20E.O.)
Sorbitan 0.5
(13) Dibutylhydroxytoluene 0.1
(14) Triethanolamine 0.5
(15) 1,3-butylene glycol 15.0
(16) Glycerol 3.0
(17) Polyethylene glycol 6000 0.5
(18) Sesame germinant extract of Production Example 3 2.0
(19) Purified water remaining amount (20) 1% aqueous solution of carboxyvinyl polymer 8.0
(21) Perfume appropriate amount

[実施例5:軟膏]
(製法)
A.成分(3)、(4)、(7)及び(8)の一部を加熱混合し、75℃に保つ。
B.成分(1)、(2)、(6)を加熱混合し、75℃に保つ。
C.AをBに徐々に加える。
D.Cを冷却しながら(8)の残部で溶解した(5)を加え、軟膏を得た。
[Example 5: Ointment]
(Manufacturing method)
A. A part of components (3), (4), (7) and (8) is heated and mixed and kept at 75 ° C.
B. Ingredients (1), (2), (6) are heated and mixed and maintained at 75 ° C.
C. Gradually add A to B.
D. (5) dissolved in the remainder of (8) was added while cooling C to obtain an ointment.

(成分) (%)
(1)ステアリン酸 15.0
(2)セタノール 7.0
(3)トリエタノールアミン 2.0
(4)グリセリン 7.0
(5)製造例1のゴマ発芽体抽出物 1.0
(6)グリチルレチン酸ステアリル 0.5
(7)D−パンテノール 1.0
(8)精製水 残量
(Ingredient) (%)
(1) Stearic acid 15.0
(2) Cetanol 7.0
(3) Triethanolamine 2.0
(4) Glycerin 7.0
(5) Sesame germinated extract of Production Example 1 1.0
(6) Stearyl glycyrrhetinate 0.5
(7) D-Panthenol 1.0
(8) Purified water remaining

[実施例6:クリーム]
(製法)
A.下記成分(1)〜(14)を加熱溶解し、70℃に保つ。
B.下記成分(15)〜(20)を加熱溶解し、70℃に保つ。
C.AにBを加え乳化し、更に下記成分(21)を加え混合する。
D.Cを冷却し、下記成分(22)を加え混合し、クリームを得た。
[Example 6: Cream]
(Manufacturing method)
A. The following components (1) to (14) are dissolved by heating and maintained at 70 ° C.
B. The following components (15) to (20) are dissolved by heating and maintained at 70 ° C.
C. B is added to A to emulsify, and the following component (21) is further added and mixed.
D. C was cooled, the following component (22) was added and mixed to obtain a cream.

(成分) (%)
(1)ステアリン酸 2.5
(2)セタノール 2.5
(3)モノステアリン酸グリセリン 2.0
(4)ワセリン 2.0
(5)ジペンタエリトリット脂肪酸エステル 2.0
(6)ミリスチン酸イソトリデシル 5.0
(7)流動パラフィン 8.0
(8)スクワラン 5.0
(9)ミツロウ 1.0
(10)パルミチン酸セチル 2.0
(11)セスキオレイン酸ソルビタン 0.5
(12)モノオレイン酸ポリオキシエチレン(20E.O.)
ソルビタン 1.5
(13)コエンザイムQ10 0.3
(14)防腐剤 適量
(15)トリエタノールアミン 1.2
(16)1,3−ブチレングリコール 8.0
(17)グリセリン 2.0
(18)ポリエチレングリコール20000 0.5
(19)製造例2のゴマ発芽体抽出物 0.01
(20)精製水 残量
(21)カルボキシビニルポリマー1%水溶液 10.0
(22)香料 適量
(Ingredient) (%)
(1) Stearic acid 2.5
(2) Cetanol 2.5
(3) Glycerin monostearate 2.0
(4) Vaseline 2.0
(5) Dipentaerythritol fatty acid ester 2.0
(6) Isotridecyl myristate 5.0
(7) Liquid paraffin 8.0
(8) Squalane 5.0
(9) Beeswax 1.0
(10) Cetyl palmitate 2.0
(11) Sorbitan sesquioleate 0.5
(12) Polyoxyethylene monooleate (20E.O.)
Sorbitan 1.5
(13) Coenzyme Q10 0.3
(14) Preservative appropriate amount (15) Triethanolamine 1.2
(16) 1,3-butylene glycol 8.0
(17) Glycerin 2.0
(18) Polyethylene glycol 20000 0.5
(19) Sesame germinant extract of Production Example 2 0.01
(20) Purified water remaining amount (21) Carboxyvinyl polymer 1% aqueous solution 10.0
(22) Perfume appropriate amount

[実施例7:油中水型日焼け止めクリーム]
(製法)
A.下記成分(1)〜(8)を70℃で加熱混合した。
B.下記成分(9)〜(12)及び(14)〜(15)を50℃で加温混合した。
C.AにBを加えて乳化し、冷却後(13)を添加して油中水型日焼け止めクリームを得た。
[Example 7: Water-in-oil type sunscreen cream]
(Manufacturing method)
A. The following components (1) to (8) were heated and mixed at 70 ° C.
B. The following components (9) to (12) and (14) to (15) were heated and mixed at 50 ° C.
C. B was added to A to emulsify, and after cooling, (13) was added to obtain a water-in-oil sunscreen cream.

(成分) (%)
(1)ポリオキシアルキレン変性オルガノポリシロキサン(注1) 2.0
(2)パルミチン酸オクチル 15.0
(3)デカメチルシクロペンタシロキサン 20.0
(4)トリベヘン酸グリセリル 1.0
(5)微粒子酸化亜鉛 12.0
(6)微粒子酸化チタン 3.0
(7)パラメトキシケイ皮酸2−エチルヘキシル(注2) 7.0
(8)4−tertブチル−4’−メトキシジベンゾイルメタン
(注3) 1.0
(9)ジプロピレングリコール 5.0
(10)エタノール 5.0
(11)ポリエチレン末 3.0
(12)防腐剤 適量
(13)香料 適量
(14)製造例3のゴマ発芽体抽出物 0.1
(15)精製水 残量
(注1)KF−6017(信越化学工業社製)
(注2)ユビナールMC80(BASF社製)
(注3)PARSOL 1789(L.C.UNITED社製)
(Ingredient) (%)
(1) Polyoxyalkylene-modified organopolysiloxane (Note 1) 2.0
(2) Octyl palmitate 15.0
(3) Decamethylcyclopentasiloxane 20.0
(4) Glyceryl tribehenate 1.0
(5) Fine zinc oxide 12.0
(6) Fine particle titanium oxide 3.0
(7) 2-Methylhexyl paramethoxycinnamate (Note 2) 7.0
(8) 4-tertbutyl-4′-methoxydibenzoylmethane
(Note 3) 1.0
(9) Dipropylene glycol 5.0
(10) Ethanol 5.0
(11) Polyethylene powder 3.0
(12) Preservative Appropriate amount (13) Fragrance Appropriate amount (14) Sesame seed extract of Production Example 3 0.1
(15) Remaining amount of purified water (Note 1) KF-6017 (manufactured by Shin-Etsu Chemical Co., Ltd.)
(Note 2) Yubinar MC80 (BASF)
(Note 3) PARSOL 1789 (manufactured by LC UNITED)

[実施例8:パック化粧料]
(製法)
A.下記成分(1)〜(6)及び(15)を70℃で加熱混合し、室温まで冷却する。
B.Aに下記成分(7)〜(14)を添加混合してパック化粧料を得た。
[Example 8: Pack cosmetic]
(Manufacturing method)
A. The following components (1) to (6) and (15) are heated and mixed at 70 ° C. and cooled to room temperature.
B. The following components (7) to (14) were added to A and mixed to obtain a pack cosmetic.

(成分) (%)
(1)ポリビニルアルコール 15.0
(2)グリセリン 10.0
(3)ポリオキシエチレンメチルグルコシド 3.0
(4)トリオクタン酸グリセリル 5.0
(5)グリチルレチン酸ステアリル 0.1
(6)ポリオキシエチレンアルキルエーテルリン酸ナトリウム 1.0
(7)エタノール 20.0
(8)カオリン 2.0
(9)酸化チタン 2.0
(10)乳酸(50%水溶液) 0.5
(11)乳酸ナトリウム(50%水溶液) 0.5
(12)防腐剤 適量
(13)香料 適量
(14)製造例1のゴマ発芽体抽出物 0.2
(15)精製水 残量
(Ingredient) (%)
(1) Polyvinyl alcohol 15.0
(2) Glycerin 10.0
(3) Polyoxyethylene methyl glucoside 3.0
(4) Glyceryl trioctanoate 5.0
(5) Stearyl glycyrrhetinate 0.1
(6) Sodium polyoxyethylene alkyl ether phosphate 1.0
(7) Ethanol 20.0
(8) Kaolin 2.0
(9) Titanium oxide 2.0
(10) Lactic acid (50% aqueous solution) 0.5
(11) Sodium lactate (50% aqueous solution) 0.5
(12) Preservative Appropriate amount (13) Fragrance Appropriate amount (14) Sesame germinated extract of Production Example 1 0.2
(15) Purified water remaining

[実施例9:リキッドファンデーション]
(製法)
A.下記成分(1)〜(7)を70℃で加熱混合し、この混合物に下記成分(13)〜(18)を加えて混合し70℃に保つ。
B.下記成分(8)〜(12)を70℃で加熱混合する。
C.BにAを加えて乳化し、冷却後、下記成分(19)〜(20)を添加してリキッドファンデーションを得た。
[Example 9: Liquid foundation]
(Manufacturing method)
A. The following components (1) to (7) are heated and mixed at 70 ° C., and the following components (13) to (18) are added to the mixture and mixed to maintain at 70 ° C.
B. The following components (8) to (12) are heated and mixed at 70 ° C.
C. A was added to B to emulsify, and after cooling, the following components (19) to (20) were added to obtain a liquid foundation.

(成分) (%)
(1)ジペンタエリトリット脂肪酸エステル 2.0
(2)流動パラフィン 5.0
(3)ステアリン酸 2.0
(4)セタノール 1.0
(5)モノステアリン酸グリセリル 1.0
(6)パラメトキシケイ皮酸2−エチルヘキシル 8.0
(7)防腐剤 適量
(8)グリセリン 5.0
(9)トリエタノールアミン 1.0
(10)カルボキシメチルセルロース 0.2
(11)ベントナイト 0.5
(12)精製水 残量
(13)酸化チタン 6.0
(14)微粒子酸化チタン 2.0
(15)微粒子酸化亜鉛 4.0
(16)マイカ 2.0
(17)タルク 4.0
(18)着色顔料 適量
(19)製造例2のゴマ発芽体抽出物 1.0
(20)香料 適量
(Ingredient) (%)
(1) Dipentaerythritol fatty acid ester 2.0
(2) Liquid paraffin 5.0
(3) Stearic acid 2.0
(4) Cetanol 1.0
(5) Glyceryl monostearate 1.0
(6) 2-Methylhexyl paramethoxycinnamate 8.0
(7) Preservative appropriate amount (8) Glycerin 5.0
(9) Triethanolamine 1.0
(10) Carboxymethylcellulose 0.2
(11) Bentonite 0.5
(12) Purified water remaining amount (13) Titanium oxide 6.0
(14) Fine particle titanium oxide 2.0
(15) Fine zinc oxide 4.0
(16) Mica 2.0
(17) Talc 4.0
(18) Appropriate amount of color pigment (19) Sesame germinated extract of Production Example 2 1.0
(20) Perfume appropriate amount

上記で調製した種々の化粧料又は皮膚外用剤は、皮膚に適用することにより、肌のしわやたるみを改善し、ハリのある美しい肌にする、老化防止効果にすぐれたものであった。
The various cosmetics or external preparations for skin prepared as described above were excellent in the anti-aging effect by applying to the skin to improve the wrinkles and sagging of the skin and to make the skin beautiful and firm.

Claims (1)

ゴマ(Pedaliaceae)科ゴマ(Sesamum)属ゴマ(Sesamuun
indicum L.)の種子発芽体より抽出されたゴマ種子発芽体抽出物を有効成分とするエラスターゼ活性阻害剤。

Sesame (Pedaliaceae) Sesamum Sesame (Sesamuun)
indicum L.) An elastase activity inhibitor comprising, as an active ingredient, a sesame seed germinant extract extracted from a seed germinant.

JP2010065594A 2010-03-23 2010-03-23 Elastase activity inhibitor Active JP5749445B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2010065594A JP5749445B2 (en) 2010-03-23 2010-03-23 Elastase activity inhibitor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2010065594A JP5749445B2 (en) 2010-03-23 2010-03-23 Elastase activity inhibitor

Publications (2)

Publication Number Publication Date
JP2011195523A true JP2011195523A (en) 2011-10-06
JP5749445B2 JP5749445B2 (en) 2015-07-15

Family

ID=44874177

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010065594A Active JP5749445B2 (en) 2010-03-23 2010-03-23 Elastase activity inhibitor

Country Status (1)

Country Link
JP (1) JP5749445B2 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08208685A (en) * 1995-02-06 1996-08-13 Nisshin Oil Mills Ltd:The Hydroxy free radical eliminating activator
JPH10279441A (en) * 1997-04-01 1998-10-20 Nisshin Oil Mills Ltd:The Hair cosmetic
JP2002255734A (en) * 2001-03-01 2002-09-11 Mitsui Chemicals Inc Elastase activity inhibitor and anti-aging agent comprising the same
JP2004532269A (en) * 2001-06-01 2004-10-21 コグニス・フランス・ソシエテ・アノニム Cosmetic preparation containing germinated plant extract
JP2008239545A (en) * 2007-03-27 2008-10-09 Kose Corp Elastase deactivator

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08208685A (en) * 1995-02-06 1996-08-13 Nisshin Oil Mills Ltd:The Hydroxy free radical eliminating activator
JPH10279441A (en) * 1997-04-01 1998-10-20 Nisshin Oil Mills Ltd:The Hair cosmetic
JP2002255734A (en) * 2001-03-01 2002-09-11 Mitsui Chemicals Inc Elastase activity inhibitor and anti-aging agent comprising the same
JP2004532269A (en) * 2001-06-01 2004-10-21 コグニス・フランス・ソシエテ・アノニム Cosmetic preparation containing germinated plant extract
JP2008239545A (en) * 2007-03-27 2008-10-09 Kose Corp Elastase deactivator

Also Published As

Publication number Publication date
JP5749445B2 (en) 2015-07-15

Similar Documents

Publication Publication Date Title
KR101186081B1 (en) Functional powders
JP2007210915A (en) Skin preparation for external use
JP2008239545A (en) Elastase deactivator
JP6689024B2 (en) External skin preparation
JP3987793B2 (en) Topical skin preparation
JP2014240375A (en) Cosmetic
JP6510744B2 (en) Cosmetics
JP2011195539A (en) Elastase activity inhibitor
JP5226200B2 (en) Sulfated glycosaminoglycan production promoter and skin external preparation containing the same
JP2013184942A (en) Antioxidant and dna damage inhibitor
JP2010150173A (en) Skin whitening agent, melanogenesis inhibitor, and skin whitening skin external preparation
JP2012201615A (en) Elastase activity inhibitor
JP4088021B2 (en) Skin external preparation and skin external preparation composition
JP4203325B2 (en) Skin external preparation and skin external preparation composition
JP2015134737A (en) External preparation for skin
JP5749445B2 (en) Elastase activity inhibitor
JP2013032331A (en) Lipid production-inhibiting agent, sebum production-inhibiting agent, and triacylglycerol production-inhibiting agent
JP2009256326A (en) Skin whitening preparation, and skincare preparation
JP2009249366A (en) Collagen production promotor and anti-aging skin preparation for external use
JP2009234976A (en) Cell activator and external preparation for skin for antiaging
JP2011195542A (en) Elastase activity inhibitor
JP2011195540A (en) Elastase activity inhibitor
JP2011195524A (en) Elastase activity inhibitor
JP2011195525A (en) Elastase activity inhibitor
KR20070111025A (en) Anti-wrinkle cosmetic compositions comprising the extract of phaseolus radiatus as active ingredient

Legal Events

Date Code Title Description
RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20130206

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20130207

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20131220

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140422

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140618

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20141202

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150224

A911 Transfer of reconsideration by examiner before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20150303

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20150421

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20150514

R150 Certificate of patent or registration of utility model

Ref document number: 5749445

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250